macular degeneration glp 1 The use of GLP-1 receptor agonists was associated with a substantially lower long-term risk for dry age-related than the use of other weight-loss medications in adults with overweight or obesity Do glp1 drugs cause macular

A Google Trends study published in the National Library of Medicine found a significant and growing public interest in GLP-1 agonists between 2023 and 2024

I had my first PRP appointment on February 24, 2025, and nothing could have prepared me for what was in store for my scalp

On the manufacturer side, Benefits and Pensions Monitor , citing Reuters and The Globe and Mail , reported that Eli Lilly planned to cut the Canadian list price of a four-week supply of Mounjaro and Zepbound to $300 for the 2.5 mg and 5 mg doses and $420 for the 7.5 mg and 10 mg doses, with the new prices taking effect December 29

Autophagy and cardiometabolic risk factors

ALC also is involved in regulating gene activity (epigenetics) and is a versatile protective nutrient for the nervous system.